NCT06723015Enrolling by invitationPhase 2
Tau PET Outcomes With Anti-amyloid Immunotherapies
Study of Tau PET Outcomes in Patients Receiving Anti-amyloid Immunotherapies
Source: ClinicalTrials.gov · Last updated 30 Oct 2026
Brief summary (registry, in English)
This is an imaging study of patients with mild Alzheimer's disease receiving amyloid-targeting therapy and under the care of neurologists at Mayo Clinic in Rochester, MN.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 135 (estimated)
- First submitted
- 5 Dec 2024
- Start date
- 4 Nov 2025
- Primary completion date
- Aug 2028
- Lead sponsor
- Mayo Clinic
- Diseases
- Alzheimer disease
- NCT number
- NCT06723015
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 135
- From 4 Nov 2025 to the primary completion date, Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects unable to lie down without moving for 10 minutes.
- Women who are pregnant or cannot stop breast feeding for 24 hours.
- Claustrophobic patients unable to tolerate the scans (no sedation can be offered).
Who the study is looking for
- Age 50-90 years
- Male or female
- Mild cognitive impairment due to AD or mild AD
- Amyloid positive via CSF or PET
- Meets other eligibility criteria for anti-amyloid immunotherapy
- Subject or delegate provides informed consent
Age in the registry: 50 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.